Nkarta: Going Down Despite Solid Data Due To Fate's Debacle [Seeking Alpha]
Nkarta, Inc. (NKTX)
Company Research
Source: Seeking Alpha
Pgiam/iStock via Getty ImagesNkarta (NASDAQ:NKTXFATEfall after that, and it remains speculative whether the fall was due to the market seeing NK cell programs in a poor light after Fateâ??s disaster, or something else. IcoveredNKTX in November, where I was generally bullish, but it needs further coverage after Fate'sproblemsHowever, comparisons end here - Nkarta, with just 8 years in existence, has produced much better data than Fate, which has been around for over 15 years. I discussed some of that data when I last covered it in November. There I said that phase 1 data from NKX101 is at least as good as Fateâ??s FT596. One difference is that FT596 usesinduced pluripotent stem cells while NKX101 uses stem cells from healthy donors. Another major difference: FT596 is now no more, while NKX101 is progressing in fits and bounds - to mix up a couple of English idioms.Now, if you look at some of FT596In the second and third single-dose cohorts of the Monotherapy and Combination Arms compri
Show less
Read more
Impact Snapshot
Event Time:
NKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NKTX alerts
High impacting Nkarta, Inc. news events
Weekly update
A roundup of the hottest topics
NKTX
News
- Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights [Yahoo! Finance]Yahoo! Finance
- Nkarta Reports First Quarter 2024 Financial Results and Corporate HighlightsGlobeNewswire
- CD70 Antibodies CD70 Targeting Therapies Clinical Trials Market Opportunity Insight [Yahoo! Finance]Yahoo! Finance
- Nkarta: Down 50% Since March With A Clinical Catalyst Ahead [Seeking Alpha]Seeking Alpha
- Nkarta, Inc. (NASDAQ: NKTX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.MarketBeat
NKTX
Earnings
- 5/9/24 - Miss
NKTX
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/25/24 - Form ARS
- NKTX's page on the SEC website